Literature DB >> 7264811

The use of betaine for the treatment of homocystinuria.

L A Smolin, N J Benevenga, S Berlow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7264811     DOI： 10.1016/s0022-3476(81)80352-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  18 in total

1.  Studies on the protective effects of betaine against oxidative damage during experimentally induced restraint stress in Wistar albino rats.

Authors:  Balaraman Ganesan; Rangasamy Anandan; Pindath Thandayan Lakshmanan
Journal:  Cell Stress Chaperones       Date:  2011-06-30       Impact factor: 3.667

2.  Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy.

Authors:  Nigel J Manning; Elizabeth K Allen; Richard J Kirk; Mark J Sharrard; Edwin J Smith
Journal:  JIMD Rep       Date:  2011-11-20

3.  Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria.

Authors:  Tomas Majtan; Helena Hůlková; Insun Park; Jakub Krijt; Viktor Kožich; Erez M Bublil; Jan P Kraus
Journal:  FASEB J       Date:  2017-08-16       Impact factor: 5.191

4.  The natural history of vascular disease in homocystinuria and the effects of treatment.

Authors:  D E Wilcken; B Wilcken
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

5.  Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria.

Authors:  Tomas Majtan; Wendell Jones; Jakub Krijt; Insun Park; Warren D Kruger; Viktor Kožich; Steven Bassnett; Erez M Bublil; Jan P Kraus
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

6.  Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.

Authors:  U Wendel; H J Bremer
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

7.  Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria.

Authors:  Bernd C Schwahn; Dieter Hafner; Thomas Hohlfeld; Nina Balkenhol; Maurice D Laryea; Udo Wendel
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

8.  An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria.

Authors:  Angela Matthews; Trevor N Johnson; Amin Rostami-Hodjegan; Anupam Chakrapani; J Edward Wraith; Stuart J Moat; James R Bonham; Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

9.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

10.  The effect of oral betaine on vertebral body bone density in pyridoxine-non-responsive homocystinuria.

Authors:  W A Gahl; I Bernardini; S Chen; D Kurtz; K Horvath
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.